Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Elliott

Showing results (61-70 of 157) with videos related to

Pageof 16
Sort By:
ACS Omega|February 1, 2021
Synthesis of Radiolabeled Technetium- and Rhenium-Luteinizing Hormone-Releasing Hormone (<sup>99m</sup>Tc/Re-Acdien-LHRH) Conjugates for Targeted Detection of Breast Cancer Cells Overexpressing the LHRH ReceptorLindsay E Calderon, Carrie A Black, Joseph D Rollins, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and OutcomesDipesh Uprety, Kieran Sweeney, Lubina Arjyal, et al.
Breast Cancer Research and Treatment|August 11, 2020
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathwayArielle L Heeke, Joanne Xiu, Andrew Elliott, et al.
Scientific Reports|February 10, 2024
ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomesFavour A Akinjiyan, George Nassief, Jordan Phillipps, et al.
BMJ Open|December 22, 2023
Development and application of simulation modelling for orthopaedic elective resource planning in EnglandAlison Harper, Thomas Monks, Rebecca Wilson, et al.
Cancer Treatment and Research Communications|April 30, 2026
The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs) including small-cell lung cancer (SCLC)Samuel A Kareff, Harris Krause, Andrew Elliott, et al.
JCO Precision Oncology|January 14, 2026
Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient CohortGeorge Nassief, Tolulope Adeyelu, Andrew Elliott, et al.
Clinical Lung Cancer|October 9, 2024
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung CancerAlexander S Watson, Harris B Krause, Andrew Elliott, et al.
Gynecologic Oncology|October 4, 2024
Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinomaTullia Rushton, Harris B Krause, Timothy Samec, et al.
Molecular Cancer Research : MCR|June 24, 2024
Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate CancerSharon H Choi, Elizabeth Pan, Andrew Elliott, et al.
Pageof 16

Showing results (61-70 of 157) with videos related to

Sort By:
Pageof 16
ACS Omega|February 1, 2021
Synthesis of Radiolabeled Technetium- and Rhenium-Luteinizing Hormone-Releasing Hormone (<sup>99m</sup>Tc/Re-Acdien-LHRH) Conjugates for Targeted Detection of Breast Cancer Cells Overexpressing the LHRH ReceptorLindsay E Calderon, Carrie A Black, Joseph D Rollins, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and OutcomesDipesh Uprety, Kieran Sweeney, Lubina Arjyal, et al.
Breast Cancer Research and Treatment|August 11, 2020
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathwayArielle L Heeke, Joanne Xiu, Andrew Elliott, et al.
Scientific Reports|February 10, 2024
ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomesFavour A Akinjiyan, George Nassief, Jordan Phillipps, et al.
BMJ Open|December 22, 2023
Development and application of simulation modelling for orthopaedic elective resource planning in EnglandAlison Harper, Thomas Monks, Rebecca Wilson, et al.
Cancer Treatment and Research Communications|April 30, 2026
The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs) including small-cell lung cancer (SCLC)Samuel A Kareff, Harris Krause, Andrew Elliott, et al.
JCO Precision Oncology|January 14, 2026
Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient CohortGeorge Nassief, Tolulope Adeyelu, Andrew Elliott, et al.
Clinical Lung Cancer|October 9, 2024
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung CancerAlexander S Watson, Harris B Krause, Andrew Elliott, et al.
Gynecologic Oncology|October 4, 2024
Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinomaTullia Rushton, Harris B Krause, Timothy Samec, et al.
Molecular Cancer Research : MCR|June 24, 2024
Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate CancerSharon H Choi, Elizabeth Pan, Andrew Elliott, et al.
Pageof 16